Neurology 2003;61:108-110
© 2003 American Academy of Neurology
Brief Communications
Neuropsychiatric lupus syndromes
Relationship with antiphospholipid antibodies
Antonella Afeltra, MD,
Pierluigi Garzia, MD,
Anna Paola Mitterhofer, MD,
Marta Vadacca, MD,
Sara Galluzzo, MD,
Flavia Del Porto, MD,
Licia Finamore, MD,
Stefano Pascucci, MD,
Marina Gasparini, MD,
Bruno Laganà, MD,
Domenico Caccavo, MD,
Giovanni Maria Ferri, MD,
Antonio Amoroso, MD and
Ada Francia, MD
From the University "Campus Bio-Medico" (Drs. Afeltra and Vadacca), Rome, Italy; Departments of Clinical Medicine (Drs. Garzia, Mitterhofer, Galluzzo, Del Porto, Laganà, Ferri, and Amoroso) and Neurological Sciences (Drs. Finamore, Pascucci, Gasparini, and Francia), University "La Sapienza," Rome, Italy; and Department of Clinical Medicine, Immunology, and Infectious Diseases (Dr. Caccavo), University of Bari, Italy.
Address correspondence and reprint requests to Prof. A. Afeltra, University "Campus Bio-Medico," Via E. Longoni 83, 00155 Rome, Italy; e-mail: a.afeltra{at}unicampus.it
The authors assessed the prevalence of neuropsychiatric manifestations occurring in patients with systemic lupus erythematosus (NPSLE), according to the American College of Rheumatology standardized definitions for NPSLE, and evaluated the relationship between NPSLE and antiphospholipid antibodies. Sixty-one consecutive SLE patients were studied. Neuropsychiatric manifestations consistent with the diagnosis of NPSLE occurred in 44 (72%). Patients with NPSLE showed significantly higher levels of anticardiolipin antibodies.
This article has been cited by other articles:

|
 |

|
 |
 
E Harboe, A B Tjensvoll, S Maroni, L G Goransson, O J Greve, M K Beyer, A Herigstad, J T Kvaloy, and R Omdal
Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjogren syndrome: a comparative population-based study
Ann Rheum Dis,
October 1, 2009;
68(10):
1541 - 1546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T Rizos, M Siegelin, S Hahnel, B Storch-Hagenlocher, and A Hug
Fulminant onset of cerebral immunocomplex vasculitis as first manifestation of neuropsychiatric systemic lupus erythematosus (NPSLE)
Lupus,
April 1, 2009;
18(4):
361 - 363.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S Appenzeller, F Cendes, and L. Costallat
Cerebellar ataxia in systemic lupus erythematosus
Lupus,
December 1, 2008;
17(12):
1122 - 1126.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Pego-Reigosa and D. A. Isenberg
Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease
Rheumatology,
October 1, 2008;
47(10):
1498 - 1502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. G. Joseph, G. A. Lammie, and N. J. Scolding
CNS lupus: A study of 41 patients
Neurology,
August 14, 2007;
69(7):
644 - 654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A Mikdashi
Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials
Lupus,
June 1, 2007;
16(6):
418 - 425.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Parikh, K. Shifteh, M.L. Lipton, J.A. Bello, and A.L. Brook
Deep Brain Reversible Encephalopathy: Association with Secondary Antiphospholipid Antibody Syndrome
AJNR Am. J. Neuroradiol.,
January 1, 2007;
28(1):
76 - 78.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-H. J. Cha, K. Furie, J. Kay, R. P. Walensky, M. E. Mullins, and E. T. Hedley-Whyte
Case 39-2006 -- A 24-Year-Old Woman with Systemic Lupus Erythematosus, Seizures, and Right Arm Weakness
N. Engl. J. Med.,
December 21, 2006;
355(25):
2678 - 2689.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R Cimaz, P L Meroni, and Y Shoenfeld
Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome)
Lupus,
April 1, 2006;
15(4):
191 - 197.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F-G Lehnhardt, C Scheid, U Holtik, L Burghaus, M Neveling, P Impekoven, A Ruger, M Hallek, A H Jacobs, and A Rubbert
Autologous blood stem cell transplantation in refractory systemic lupus erythematodes with recurrent longitudinal myelitis and cerebral infarction
Lupus,
April 1, 2006;
15(4):
240 - 243.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Statkute, A. Traynor, Y. Oyama, K. Yaung, L. Verda, N. Krosnjar, and R. K. Burt
Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation
Blood,
October 15, 2005;
106(8):
2700 - 2709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M H Houman, M Smiti-Khanfir, I B. Ghorbell, and M Miled
Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients
Lupus,
March 1, 2004;
13(3):
204 - 211.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
O Nived, G Sturfelt, M H Liang, and P De Pablo
The ACR nomenclature for CNS lupus revisited
Lupus,
December 1, 2003;
12(12):
872 - 876.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Brey and M. A. Petri
Neuropsychiatric systemic lupus erythematosus: Miles to go before we sleep
Neurology,
July 8, 2003;
61(1):
9 - 10.
[Full Text]
[PDF]
|
 |
|
|